PE57194A1 - Hidroxiurea de fenoxifenil ciclopentenil - Google Patents

Hidroxiurea de fenoxifenil ciclopentenil

Info

Publication number
PE57194A1
PE57194A1 PE1994248312A PE24831294A PE57194A1 PE 57194 A1 PE57194 A1 PE 57194A1 PE 1994248312 A PE1994248312 A PE 1994248312A PE 24831294 A PE24831294 A PE 24831294A PE 57194 A1 PE57194 A1 PE 57194A1
Authority
PE
Peru
Prior art keywords
pct
date
above compounds
phenoxifenil
ciclopentenil
Prior art date
Application number
PE1994248312A
Other languages
English (en)
Inventor
Rodney W Stevens
Akiyoshi Kawai
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PE57194A1 publication Critical patent/PE57194A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I DONDE: a) R1 ES HIDROGENO, FLUOR, CLORO; b) R2 ES HIDROGENO, METILO; PREFIRIENDOSE EL ISOMERO DEXTROGIRATORIO, EL CUAL INHIBE A LA ENZIMA 5-LIPOXIGENASA QUE ESTA RELACIONADA CON LA FORMACION DE LEUCOTRIENOS Y PUEDE SER UTIL EN EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS Y ALERGICAS
PE1994248312A 1993-08-19 1994-08-11 Hidroxiurea de fenoxifenil ciclopentenil PE57194A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20545393 1993-08-19

Publications (1)

Publication Number Publication Date
PE57194A1 true PE57194A1 (es) 1995-02-07

Family

ID=16507136

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1994248312A PE57194A1 (es) 1993-08-19 1994-08-11 Hidroxiurea de fenoxifenil ciclopentenil

Country Status (27)

Country Link
US (1) US5792882A (es)
EP (1) EP0720598B1 (es)
JP (1) JP2794343B2 (es)
KR (1) KR0170623B1 (es)
CN (1) CN1077568C (es)
AT (1) ATE171939T1 (es)
AU (1) AU674776B2 (es)
BR (1) BR9407314A (es)
CA (1) CA2169066C (es)
CO (1) CO4230229A1 (es)
CZ (1) CZ288358B6 (es)
DE (1) DE69413831T2 (es)
DK (1) DK0720598T3 (es)
EC (1) ECSP941144A (es)
EG (1) EG20530A (es)
ES (1) ES2121218T3 (es)
FI (1) FI114466B (es)
IL (1) IL110628A (es)
MY (1) MY111140A (es)
NO (1) NO305595B1 (es)
NZ (1) NZ269849A (es)
PE (1) PE57194A1 (es)
PL (1) PL176223B1 (es)
RU (1) RU2125987C1 (es)
TW (2) TW418089B (es)
WO (1) WO1995005360A1 (es)
ZA (1) ZA946253B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9606635A (es) * 1994-06-27 1997-12-31 Cytomed Inc Compuestos y metodos para el tratamiento de desordenes cardiovasculares, inflamatorios e inmunes.
MX9703485A (es) * 1994-11-10 1997-08-30 Pfizer Ariloxicicloalquenil-y ariloxiiminocicloalquenilhidroxiureas.
WO1996016054A1 (en) * 1994-11-18 1996-05-30 Pfizer Pharmaceuticals Inc. Cycloalkenyl-n-hydroxyureas
EP1745774A3 (en) 1997-08-11 2007-04-11 Pfizer Products Inc. Solid pharmaceutical dispersions with enhanced bioavailability
US6121323A (en) * 1997-12-03 2000-09-19 3M Innovative Properties Company Bishydroxyureas
CN101068774B (zh) * 2004-12-02 2011-08-10 株式会社Amorepacific 抑制TNF-α形成的2-环戊烯-1-酮肟衍生物
KR101567571B1 (ko) 2007-12-03 2015-11-11 (주)아모레퍼시픽 2-사이클로펜텐-1-온 옥심 유도체를 유효성분으로 포함하는 슬리밍 화장료 조성물
MY172424A (en) 2009-04-03 2019-11-25 Hoffmann La Roche Propane- i-sulfonic acid {3- (4-chloro-phenyl)-1h-pyrrolo [2, 3-b] pyridine-3-carconyl] -2, 4-difluoro-phenyl} -amide compositions and uses thereof
US8512464B2 (en) * 2009-12-02 2013-08-20 3M Innovative Properties Company Functionalized zirconia nanoparticles and high index films made therefrom

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222168A (en) * 1986-10-20 1991-05-28 Oncogene Science Inc Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
ES2060015T3 (es) * 1989-02-03 1994-11-16 Wellcome Found Derivados arilicos anti-inflamatorios.
US5120752A (en) * 1989-12-28 1992-06-09 Abbott Laboratories Cyclopropyl derivative lipoxygenase inhibitors
GB9025514D0 (en) * 1990-11-23 1991-01-09 Wellcome Found Anti-inflammatory compounds
JP3007138B2 (ja) * 1990-11-27 2000-02-07 ファイザー製薬株式会社 新規なヒドロキサム酸とｎ―ヒドロキシ尿素誘導体およびそれらの組成物
JPH06256285A (ja) * 1990-12-11 1994-09-13 Pfizer Pharmaceut Co Ltd ヒドロキサム酸誘導体およびその用途
JPH05163229A (ja) * 1991-12-13 1993-06-29 Pfizer Pharmaceut Co Ltd 新規なシクロプロピル誘導体
JPH05294921A (ja) * 1992-04-17 1993-11-09 Pfizer Pharmaceut Co Ltd 新規なフェニル置換シクロアルキル尿素誘導体および組成物

Also Published As

Publication number Publication date
US5792882A (en) 1998-08-11
WO1995005360A1 (en) 1995-02-23
AU674776B2 (en) 1997-01-09
CZ288358B6 (en) 2001-05-16
AU7350994A (en) 1995-03-14
CN1077568C (zh) 2002-01-09
FI114466B (fi) 2004-10-29
TW448144B (en) 2001-08-01
ATE171939T1 (de) 1998-10-15
NO305595B1 (no) 1999-06-28
FI943799A (fi) 1995-02-20
CA2169066C (en) 1999-06-22
IL110628A0 (en) 1994-11-11
NZ269849A (en) 1997-10-24
KR0170623B1 (ko) 1999-03-30
CZ48396A3 (en) 1996-07-17
PL176223B1 (pl) 1999-05-31
TW418089B (en) 2001-01-11
PL313037A1 (en) 1996-05-27
EP0720598B1 (en) 1998-10-07
CN1129440A (zh) 1996-08-21
JPH08511031A (ja) 1996-11-19
KR960703845A (ko) 1996-08-31
BR9407314A (pt) 1996-04-16
EG20530A (en) 1999-07-31
RU2125987C1 (ru) 1999-02-10
FI943799A0 (fi) 1994-08-18
DE69413831T2 (de) 1999-02-25
ES2121218T3 (es) 1998-11-16
ZA946253B (en) 1996-02-19
EP0720598A1 (en) 1996-07-10
JP2794343B2 (ja) 1998-09-03
MY111140A (en) 1999-08-30
CO4230229A1 (es) 1995-10-19
NO960631D0 (no) 1996-02-16
NO960631L (no) 1996-02-16
CA2169066A1 (en) 1995-02-23
IL110628A (en) 1998-12-27
DE69413831D1 (de) 1998-11-12
ECSP941144A (es) 1995-02-27
DK0720598T3 (da) 1999-06-21

Similar Documents

Publication Publication Date Title
FI943948A (fi) Heterosykliset hiilihappojohdannaiset
ATE206123T1 (de) Phenylxanthin-derivate
FI932229A0 (fi) Azabicykliska bryggderivat
DE69505542D1 (de) 3-benzoylbenzofuran-derivate als thyroidhormonantagonisten
ES2149777T3 (es) Derivados de triazol que tienen actividad antifungica.
PE57194A1 (es) Hidroxiurea de fenoxifenil ciclopentenil
BR9507677A (pt) Composto composição farmacéutica processo para a profilaxia ou para o tratamento de condições associadas à inflamação à artrite ou à dor em um mamifero uso do composto processo para a preparação do composto e novo intermediário
ATE184593T1 (de) Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren
IL113706A (en) N-hydroxyurea alkyl phenyl oxazoles and thiazoles uses thereof as anti-inflammatory agents and pharmaceutical compositions containing them
ATE144497T1 (de) N-substituierte 3-azabicyclo(3.2.0&gt;heptan- derivate als neuroleptika
ATE177098T1 (de) Mercaptoacetylamid disulfidderivate als enkephalinase und ace inhibitoren
SE9401965D0 (sv) New compounds
FI935867A (fi) Tetrahydrobensazepinderivat som inhibiterar lipoxigenas

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed